Literature DB >> 6754572

The complete amino acid sequence of low molecular mass urokinase from human urine.

G J Steffens, W A Günzler, F Otting, E Frankus, L Flohé.   

Abstract

The sequence of all 253 amino acids of the heavy (B-) chain of human urinary urokinase was determined. The fragmentation strategy employed included cyanogen bromide cleavage of S-carboxymethylated B-chain at Met and/or Trp residues, cleavage of acid-labile Asp-Pro bonds, and the use of the specific endoproteinases Lys-C and Arg-C for generation of overlapping fragments. For sequence determination automated solid- or liquid-phase techniques of Edman degradation were used. The amino acid sequence obtained substantiates the serine protease character of the B-chain of urokinase: a considerable homology with other serine proteinases, especially with the B-chain of human plasmin, was proved. The pertinent active site amino acids were localized: His-46, Asp-97, and Ser-198. A carbohydrate side chain, containing at least 4 glucosamine and 2 galactosamine residues, was demonstrated to be fixed at asparagine in position 144. The sequence data presented, together with the sequence of the second (A1-) chain of low molecular mass urokinase which was reported by us in an earlier communication, complete the knowledge of the whole primary structure of an active form of human urinary urokinase.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6754572     DOI: 10.1515/bchm2.1982.363.2.1043

Source DB:  PubMed          Journal:  Hoppe Seylers Z Physiol Chem        ISSN: 0018-4888


  31 in total

1.  Cloning, sequencing, and expression of a Thermomonospora fusca protease gene in Streptomyces lividans.

Authors:  G Lao; D B Wilson
Journal:  Appl Environ Microbiol       Date:  1996-11       Impact factor: 4.792

2.  Urokinase has direct catalytic activity against fibrinogen and renders it less clottable by thrombin.

Authors:  J I Weitz; B Leslie
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

3.  Zymogen-activation kinetics. Modulatory effects of trans-4-(aminomethyl)cyclohexane-1-carboxylic acid and poly-D-lysine on plasminogen activation.

Authors:  L C Petersen; J Brender; E Suenson
Journal:  Biochem J       Date:  1985-01-01       Impact factor: 3.857

4.  Expression of human recombinant plasminogen activators enhances invasion and experimental metastasis of H-ras-transformed NIH 3T3 cells.

Authors:  J H Axelrod; R Reich; R Miskin
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

5.  Elastase digested urokinase (ED-UK).

Authors:  H Sumi; T Kosugi; N Toki; H Mihara
Journal:  Experientia       Date:  1985-12-15

6.  Kringle-kringle interactions in multimer kringle structures.

Authors:  K Padmanabhan; T P Wu; K G Ravichandran; A Tulinsky
Journal:  Protein Sci       Date:  1994-06       Impact factor: 6.725

7.  cDNA and gene nucleotide sequence of porcine plasminogen activator.

Authors:  Y Nagamine; D Pearson; M S Altus; E Reich
Journal:  Nucleic Acids Res       Date:  1984-12-21       Impact factor: 16.971

8.  Plasminogen activator inhibitor-1: a novel therapeutic target for hypertension?

Authors:  Daniel I Simon; Norman M Simon
Journal:  Circulation       Date:  2013-10-03       Impact factor: 29.690

9.  Identification and primary sequence of an unspliced human urokinase poly(A)+ RNA.

Authors:  P Verde; M P Stoppelli; P Galeffi; P Di Nocera; F Blasi
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

10.  Kinetics of the inhibition of plasminogen activators by the plasminogen-activator inhibitor. Evidence for 'second-site' interactions.

Authors:  J Chmielewska; M Rånby; B Wiman
Journal:  Biochem J       Date:  1988-04-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.